fig10

Influence of chlorpyrifos oxon on the development and progression of Alzheimer's disease in amyloid precursor protein transgenic mice

Figure 10. Treatment of amyloid precursor protein (APP) mice with galantamine partially attenuates the effects of chlorpyrifos oxon (CPO) on amyloid β (Aβ peptide levels and plaque load. Weaned APP mice (3-week of age) were treated with CPO (1 mg/kg) or CPO + galantamine (2 mg/kg/day, i.m.) and examined for Aβ peptide levels (a) and amyloid load (b) values are shown as the mean ± standard error of the mean, and n = 12. *Statistically significant (P < 0.05)

Neuroimmunology and Neuroinflammation
ISSN 2349-6142 (Online) 2347-8659 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/